Intraperitoneal bevacizumab for the palliation of malignant ascites in refractory ovarian cancer

Chad A. Hamilton*, G. Larry Maxwell, Mildred R. Chernofsky, Sarah A. Bernstein, John H. Farley, G. Scott Rose

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

85 Scopus citations

Fingerprint

Dive into the research topics of 'Intraperitoneal bevacizumab for the palliation of malignant ascites in refractory ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences